Explore our comprehensive coverage of fda approval, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The FDA's accelerated approval of a $1.2 million CRISPR base-editing therapy for Alzheimer's, coupled with emerging safety data on epigenetic drift, i...
Read Full Story →
Medical ResearchThe biomedical research apparatus is undergoing a painful structural migration driven by AI-driven f...
Medical ResearchThe FDA's approval of the first in vivo CRISPR base-editing therapy permanently silences the PCSK9 g...
![[The Alchemist's Ledger: Five Breakthroughs Signal the End of Symptom-Management Medicine]](https://www.crimaz.com/assets/images/no-image.png)
Medical Research[The simultaneous FDA approvals of a triple-agonist for MASH, in vivo CRISPR for hypercholesterolemi...
Medical Research[The FDA's September 2026 approval of Zanvastro for Alexander disease and oral GLP-1 obesity pills, ...
Medical ResearchRecent breakthroughs in CRISPR gene editing, GLP-1 therapies, and Alzheimer's research are colliding...
Public HealthA new obesity drug showing dramatic weight loss results is reshaping public health strategy, raising...
